Psychiatry and Clinical Neurosciences

Papers
(The TQCC of Psychiatry and Clinical Neurosciences is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
The American Journal of Psychiatry: Table of Contents156
126
High‐sensitivity C‐reactive protein and bilirubin as possible biomarkers for hikikomori in depression: A case‐control study109
Identification of schizophrenia by applying interpretable radiomics modeling with structural magnetic resonance imaging of the cerebellum80
Effectiveness of a mobile application game (NDTx‐01) in enhancing social communication skills in adolescents with autism spectrum disorder or social communication disorder: A randomized con63
Associations between self‐reported parasomnias and psychiatric illness in 370,000 patients with sleep disorders62
Hikikomori and gaming disorder tendency: A case‐control online survey for nonworking adults60
A pragmatic and evidence‐based approach to telepsychiatry—let's stop waiting for the future to arrive59
Risk of treatment discontinuation and psychiatric hospitalization associated with early dose reduction of antipsychotic treatment in first‐episode schizophrenia: A nationwide, health insurance data–ba58
Associations of conservatism and jumping to conclusions biases with aberrant salience and default mode network55
Magnetic resonance imaging–based machine learning classification of schizophrenia spectrum disorders: a meta‐analysis47
Spouse bereavement and brain pathologies: A propensity score matching study47
Impact of adverse childhood experience on physical and mental health: A life‐course epidemiology perspective46
Associations between accelerometer‐measured circadian rest‐activity rhythm, brain structural and genetic mechanisms, and dementia45
The American Journal of Psychiatry: Table of Contents39
The American Journal of Psychiatry: Table of Contents36
Japanese Abstract34
Is it possible to reconstruct the diagnostic system for psychiatric disorders based on neuroimaging findings?31
Risk of injuries requiring hospitalization in attention deficit hyperactivity disorder and the preventive effects of medication28
Primary role of dextromethorphan in prolonged toxic encephalopathy with intermittent rhythmic slow‐wave activity on electroencephalogram: A case report26
Japanese Abstract25
Neural correlates of N‐back task performance and proposal for corresponding neuromodulation targets in psychiatric and neurodevelopmental disorders24
Adjunctive berberine reduces antipsychotic‐associated weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial22
22
Congenital hypothyroidism and risk of subsequent autism spectrum disorder and attention‐deficit/hyperactivity disorder in Taiwan22
Gastrointestinal obstruction due to the pica of plastic gloves in a long‐term hospitalized patient with schizophrenia22
Acknowledgments21
Issue Information21
21
Therapeutic outcomes wide association scan of different antipsychotics in patients with schizophrenia: Randomized clinical trials and multi‐ancestry validation21
Abnormal choroid plexus, hippocampus, and lateral ventricles volumes as markers of treatment‐resistant major depressive disorder20
Issue Information20
Impact of the COVID‐19 pandemic on the incidence of patients with functional neurological disorder seen in a neurological emergency department20
Transdiagnostic approach for neuropsychiatric symptoms using neuroimage19
Differential diagnosis of dementia: A key role of general hospital psychiatry19
The American Journal of Psychiatry: Table of Contents18
Early identification of postpartum depression using machine learning18
Do autism spectrum traits run in severe anorexia nervosa?18
Association of cortical thickness and cognition with schizophrenia treatment resistance18
Association of Lithium Treatment With Reduced Left Ventricular Concentricity in Patients With Bipolar Disorder18
Bilateral theta‐burst stimulation on emotional processing in major depressive disorder: A functional neuroimaging study from a randomized, double‐blind, sham‐controlled trial18
Acknowledgment17
17
Frailty subtypes and white matter alterations in older adults without dementia16
Response to [Comment on is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”]16
Corrigendum16
Correction to “Liberating older adults from the bonds of vascular risk factors: What is their impact on financial capacity in amnestic mild cognitive impairment?”16
Long‐acting paliperidone injection as a treatment option for interictal psychosis of epilepsy: A case report16
Japanese Abstract16
Peritraumatic distress and psychological symptoms in people infected with COVID‐19 after the easing of “China's zero‐COVID policy”15
Potential Role of Anti‐Inflammatory Cytokines in Postpartum Depression: Considerations for Future Research and Improvement15
Optimal dose of vortioxetine: High dose (≥20 mg) is overestimated, lower dose (5–10 mg) may be enough for many15
Cognitive profile of psychiatric patients with coexisting enlarged ventricles and cognitive impairment: A rare cross‐diagnostic phenotype predominantly observed in schizophrenia15
Homogenization of word relationships in schizophrenia: Topological analysis of cortical semantic representations15
Effects of Extended‐Release Methylphenidate on Dopamine and Norepinephrine Transporters in Adults With Attention‐Deficit/Hyperactivity Disorder: A Longitudinal Dual‐Tracer PET15
Issue Information14
Neural responses to emotional stimuli across the dissociative spectrum: Common and specific mechanisms14
14
Chronic fatigue and affective symptoms in acute and long COVID are attributable to immune‐inflammatory pathways14
PCN Art Brut Series No. 26, Artwork Description14
Neuronal imbalance of excitation and inhibition in schizophrenia: a scoping review of gamma‐band ASSR findings14
Mental health consequences of individuals affected by the 2022 invasion of Ukraine: Target populations in Japanese mental healthcare settings14
Issue Information13
Towards a latent space cartography of subjective experience in mental health13
Depression, antidepressant use, and breast cancer incidence: results from the E3N prospective cohort13
Unveiling the potential of machine learning in schizophrenia diagnosis: A meta‐analytic study of task‐based neuroimaging data12
An automated electroencephalography algorithm to detect polymorphic delta activity in acute encephalopathy presenting as postoperative delirium12
L‐theanine combination therapy with fluvoxamine in moderate‐to‐severe obsessive–compulsive disorder: A placebo‐controlled, double‐blind, randomized trial12
Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [18F]SynVesT‐112
A circuit‐based approach to modulate hypersexuality in Parkinson's disease12
Differential genetic correlations across major psychiatric disorders between Eastern and Western countries12
Beyond body image: what body schema and motor imagery can tell us about the way patients with anorexia nervosa experience their body12
12
Disentangling cognitive inflexibility in major depressive disorder: A transcranial direct current stimulation study12
PCN Art Brut Series No. 25, Artwork Description12
11
Rethinking the organizational culture of the health system to address burnout11
Japanese Abstract11
Commentary on the article titled “Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment‐resistant depression following electroconvul11
Issue Information11
Japanese Abstract11
Neurological post‐acute sequelae of SARS‐CoV‐2 infection11
Diagnosing psychiatric disorders from history of present illness using a large‐scale linguistic model11
Psychological interventions for interoception in mental health disorders: A systematic review of randomized‐controlled trials10
The American Journal of Psychiatry: Table of Contents10
Response to [Optimal dose of vortioxetine: High dose (≥20 mg) is overestimated, lower dose (5–10 mg) may be enough for many]10
Response to [Examining the feasibility and limitations of AST‐001 as a treatment for autism spectrum disorder]10
Neuropsychiatric symptoms cluster and fluctuate over time in behavioral variant frontotemporal dementia10
Closures of psychiatric units in general hospitals undermining progress in psychiatry: A stark contrast between Japan and the world10
Brain‐derived extracellular vesicles: Potential diagnostic biomarkers for central nervous system diseases10
Manic syndrome in mitochondrial membrane protein‐associated neurodegeneration: A case report10
Gut–microbiota–brain axis by bile acids in depression10
Pro‐inflammatory cytokines and cognitive dysfunction among patients with bipolar disorder and major depression10
10
10
Response to [Palmitoylethanolamide: one molecule, different formulations]10
Japanese Abstract9
Trick or treat? It's time to rethink the role of placebo in clinical trial9
Can placebo effect save your life?9
Psychiatrist density and risk of suicide: a multilevel case‐control study based on a national sample in Taiwan9
The prevalence and risk factors of suicidal ideation in pregnancy and postpartum under the COVID‐19 pandemic in Japan9
Peripheral transcriptome of clinical high‐risk psychosis reflects symptom alteration and helps prognosis prediction9
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double‐blind, randomized, placebo‐controlled, phase 2 clinical trial9
Worry: A key player in psychopathology after acquired brain injury?9
Diagnostic progression to schizophrenia: A nationwide cohort study of 11 170 adolescents and young adults with autism spectrum disorder9
Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database9
The CORE Solution: Protecting Youth Mental Health from the Digital Pandemic9
Issue Information9
Are sleep disturbances a cause or consequence of autism spectrum disorder?9
Cortical gradient perturbation in attention deficit hyperactivity disorder correlates with neurotransmitter‐, cell type‐specific and chromosome‐ transcriptomic signatures9
PCN Art Brut Series No. 33, Artwork Description8
Issue Information8
Functional neurological disorders after COVID‐19 vaccination: Case series and literature review8
Issue Information8
Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia8
8
Japanese Abstract8
Association between the Japanese‐style diet and low prevalence of depressive symptoms: Japan Epidemiology Collaboration on Occupational Health Study8
Development of disease‐modifying therapies against Alzheimer's disease8
Issue Information8
Therapeutic Drug Monitoring of Lurasidone in Patients with Schizophrenia or Bipolar Disorder: A preliminary study8
Habenular volume changes after venlafaxine treatment in patients with major depression8
Corticostriatal causality analysis in children and adolescents with attention‐deficit/hyperactivity disorder7
Depression and lifestyle: Focusing on nutrition, exercise, and their possible relevance to molecular mechanisms7
One‐year outcomes of deep brain stimulation in refractory Tourette syndrome7
Delayed encephalopathy after carbon monoxide poisoning treated with corticosteroid monotherapy: case report7
Increased granulovacuolar degeneration in the thalamus and higher neurofibrillary tangle Braak stages in bipolar disorder7
Letter to the editor: A case of functional isolated tongue tremor–like dyskinesia after COVID‐19 vaccine7
Disrupted local beta band networks in schizophrenia revealed through graph analysis: A magnetoencephalography study7
Moderation effect of the eveningness chronotype on the relationship between ADHD tendency and Internet addiction7
Unexpected risk factors of pathological hikikomori during the COVID‐19 pandemic among working adults initially without social isolation: A longitudinal online survey7
Subjects with bipolar disorder showed different reward system activation than subjects with major depressive disorder in the monetary incentive delay task7
Toward recovery in schizophrenia: Current concepts, findings, and future research directions7
Efficacy and safety of a digital therapeutic for alcohol dependence: A multicenter, open‐label, randomized controlled trial7
Corrigendum6
PCN Art Brut Series No. 30, Artwork Description6
Hikikomori: Social withdrawal a risk factor for depression6
Resting‐state theta‐phase gamma amplitude coupling as a biomarker for the transdiagnostic dimensional approach in psychiatric disorders6
Is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”6
Genome‐wide DNA methylation profiles in the raphe nuclei of patients with autism spectrum disorder6
Neurometabolic dysregulation within the cortico‐striatal‐thalamo‐cortical circuits in obsessive‐compulsive disorder: A 1 6
DISC1 protein aggregates in cerebrospinal fluid as a potential diagnostic biomarker for first‐episode psychosis6
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study6
Modeling mental disorders in a dish6
Biological basis and psychiatric symptoms in frontotemporal dementia6
Predicting social anxiety disorder based on communication logs and social network data from a massively multiplayer online game: Using a graph neural network6
6
One month version of Hikikomori Questionnaire‐25 (HQ‐25M): Development and initial validation.6
Correction to “Cause‐specific mortality after discharge from inpatient psychiatric care in Taiwan: A national matched cohort study”6
Association of benzodiazepine and Z‐hypnotic use with cardiovascular disease risk: insights from a prospective study of 10 million people in China6
Response to [Reevaluating Antipsychotic Polypharmacy in Schizophrenia: A Broader Perspective on Social Recovery]6
Uncovering heterogeneous associations of disaster‐related traumatic experiences with subsequent mental health problems: A machine learning approach6
RETRACTED: A pilot study of the effect of transcranial magnetic stimulation treatment on cognitive dysfunction associated with post COVID‐19 condition6
Potential placebo bias in current trials of delirium prevention: a network meta‐analysis of 86 randomized controlled trials6
Late‐onset panic disorder as the initial presentation in autopsy‐confirmed dementia with Lewy bodies6
An unwelcome side‐effect of trazodone use in a trans‐male6
Acceptability of antipsychotic transdermal patch for acute schizophrenia: a systematic review and meta‐analysis5
Intermittent theta burst stimulation for negative symptoms in schizophrenia patients with moderate to severe cognitive impairment: A randomized controlled trial5
Distinct delay discounting patterns in anorexia nervosa: Comparing monetary and exercise rewards across clinical subgroups5
Neuropsychiatric symptoms and neuroimaging‐based brain age in mild cognitive impairment and early dementia: A multicenter study5
How copy number variations shape brain developmental disorders: Unraveling the synaptic puzzle5
Effects of functional polymorphisms of opioid receptor mu 1 and catechol‐O‐methyltransferase on the neural processing of pain5
Immune involvement in neuropsychiatric disorders: Insights from single‐cell transcriptomic studies5
Issue Information5
Next steps of predictive models using biological measurements in psychiatry5
The hikikomori population varies significantly depending on the definition used: Evidence from a survey in Kasama, Ibaraki, Japan5
The American Journal of Psychiatry: Table of Contents5
Neurocognitive disorders and financial altruism: A few or many steps away for financial generosity and self‐justification statements to be used in the diagnosis of brain pathology in old age?5
Neuropsychiatric aspects of long COVID: A comprehensive review5
YY1 (Yin‐Yang 1), a transcription factor regulating systemic inflammation, is involved in cognitive impairment of depression5
Altered cardiac timing neural avalanche in major depressive disorder: new insights from magnetoencephalography5
Sodium benzoate, a D‐amino acid oxidase inhibitor, improved short‐term memory in patients with mild cognitive impairment in a randomized, double‐blind, placebo‐controlled clinical trial5
Issue Information5
0.46733093261719